Scroll to Top

Volume : IV, Issue : XII, January - 2015

DEVELOPMENT OF INDUCIBLE DRUG RESISTANCE TO AMOXICILLIN AND CEPHALEXIN IN A PROBIOTIC STRAIN OF LACTOBACILLI

Anjali A Tiwari, -

By : Laxmi Book Publication

Abstract :

Probiotic must be able to benefit on host through activity in human body. Lactobacillus organisms are normal inhabitants of the human intestine and vagina. They are the main ones that produce lactic acid in the digestive tract, which is important for overall health. For the prevention of intestinal disorders, probiotics can be rendered multidrug resistance to survive in the presence of antibiotics. Isolation and identification, detection and development of antibiotic resistecein this strains of lactobacillus species from commercially available probiotics and for this antibiotic susceptibility and Development of inducible drug resistance to amoxicillin and cephalexin were done and found that isolated probiotic strain was Lactobacillus rhamnosus. It is a Gram positive, nonmotile, non sporing, rod shaped bacteria. The size of colonies of Lactobacillus rhamnosus on MRS medium was of 1mm in diameter, circular, pale yellow, concave elevation, opaque and with a smooth surface and various sugar test also performed and from this result it is concluded A new strain of Lactobacillus rhamnosus that developed was resistant to amoxicillin and cephalexin at a concentration of 70μg/mL.

Keywords :


Article :


Cite This Article :

Anjali A Tiwari, -(2015). DEVELOPMENT OF INDUCIBLE DRUG RESISTANCE TO AMOXICILLIN AND CEPHALEXIN IN A PROBIOTIC STRAIN OF LACTOBACILLI. Indian Streams Research Journal, Vol. IV, Issue. XII, http://isrj.org/UploadedData/5827.pdf

References :

  1. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  2. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  3. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  4. 526.
  5. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  6. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  7. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  8. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  9. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  10. Dairy J 8: 487-490.
  11. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  12. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  13. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  14. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  15. 2, pdf.
  16. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  17. 1046-9.
  18. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  19. 526.
  20. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  21. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  22. 526.
  23. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  24. future prospects. Gut pathogens, 1(19): 1-12.
  25. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  26. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  27. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  28. 2, pdf.
  29. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  30. 2, pdf.
  31. future prospects. Gut pathogens, 1(19): 1-12.
  32. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  33. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  34. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  35. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  36. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  37. future prospects. Gut pathogens, 1(19): 1-12.
  38. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  39. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  40. 526.
  41. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  42. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  43. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  44. Dairy J 8: 487-490.
  45. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  46. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  47. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  48. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  49. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  50. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  51. future prospects. Gut pathogens, 1(19): 1-12.
  52. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  53. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  54. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  55. Dairy J 8: 487-490.
  56. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  57. future prospects. Gut pathogens, 1(19): 1-12.
  58. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  59. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  60. future prospects. Gut pathogens, 1(19): 1-12.
  61. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  62. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  63. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  64. 2, pdf.
  65. future prospects. Gut pathogens, 1(19): 1-12.
  66. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  67. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  68. future prospects. Gut pathogens, 1(19): 1-12.
  69. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  70. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  71. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  72. future prospects. Gut pathogens, 1(19): 1-12.
  73. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  74. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  75. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  76. Microbiol, 33: 1433
  77. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  78. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  79. 1046-9.
  80. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  81. 1046-9.
  82. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  83. future prospects. Gut pathogens, 1(19): 1-12.
  84. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  85. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  86. Microbiol, 33: 1433
  87. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  88. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  89. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  90. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  91. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  92. 2, pdf.
  93. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  94. Dairy J 8: 487-490.
  95. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  96. future prospects. Gut pathogens, 1(19): 1-12.
  97. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  98. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  99. future prospects. Gut pathogens, 1(19): 1-12.
  100. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  101. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  102. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  103. Dairy J 8: 487-490.
  104. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  105. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  106. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  107. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  108. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  109. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  110. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  111. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  112. Dairy J 8: 487-490.
  113. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  114. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  115. 526.
  116. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  117. future prospects. Gut pathogens, 1(19): 1-12.
  118. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  119. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  120. Dairy J 8: 487-490.
  121. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  122. Dairy J 8: 487-490.
  123. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  124. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  125. 2, pdf.
  126. 526.
  127. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  128. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  129. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  130. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  131. 2, pdf.
  132. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  133. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  134. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  135. future prospects. Gut pathogens, 1(19): 1-12.
  136. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  137. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  138. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  139. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  140. 1046-9.
  141. Microbiol, 33: 1433
  142. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  143. Microbiol, 33: 1433
  144. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  145. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  146. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  147. 2, pdf.
  148. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  149. 2, pdf.
  150. Microbiol, 33: 1433
  151. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  152. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  153. Microbiol, 33: 1433
  154. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  155. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  156. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  157. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  158. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  159. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  160. 526.
  161. future prospects. Gut pathogens, 1(19): 1-12.
  162. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  163. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  164. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  165. future prospects. Gut pathogens, 1(19): 1-12.
  166. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  167. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  168. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  169. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  170. 1046-9.
  171. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  172. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  173. 1046-9.
  174. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  175. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  176. future prospects. Gut pathogens, 1(19): 1-12.
  177. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  178. future prospects. Gut pathogens, 1(19): 1-12.
  179. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  180. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  181. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  182. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  183. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  184. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  185. 1046-9.
  186. future prospects. Gut pathogens, 1(19): 1-12.
  187. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  188. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  189. 1046-9.
  190. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  191. Dairy J 8: 487-490.
  192. Dairy J 8: 487-490.
  193. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  194. future prospects. Gut pathogens, 1(19): 1-12.
  195. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  196. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  197. future prospects. Gut pathogens, 1(19): 1-12.
  198. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  199. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  200. future prospects. Gut pathogens, 1(19): 1-12.
  201. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  202. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  203. 2, pdf.
  204. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  205. 2, pdf.
  206. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  207. Dairy J 8: 487-490.
  208. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  209. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  210. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  211. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  212. Microbiol, 33: 1433
  213. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  214. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  215. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  216. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  217. 2, pdf.
  218. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  219. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  220. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  221. 526.
  222. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  223. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  224. future prospects. Gut pathogens, 1(19): 1-12.
  225. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  226. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  227. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  228. Dairy J 8: 487-490.
  229. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  230. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  231. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  232. future prospects. Gut pathogens, 1(19): 1-12.
  233. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  234. future prospects. Gut pathogens, 1(19): 1-12.
  235. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  236. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  237. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  238. future prospects. Gut pathogens, 1(19): 1-12.
  239. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  240. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  241. future prospects. Gut pathogens, 1(19): 1-12.
  242. 1046-9.
  243. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  244. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  245. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  246. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  247. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  248. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  249. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  250. 1046-9.
  251. Dairy J 8: 487-490.
  252. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  253. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  254. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  255. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  256. 2, pdf.
  257. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  258. Dairy J 8: 487-490.
  259. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  260. Microbiol, 33: 1433
  261. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  262. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  263. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  264. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  265. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  266. 2, pdf.
  267. 1046-9.
  268. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  269. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  270. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  271. 2, pdf.
  272. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  273. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  274. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  275. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  276. 2, pdf.
  277. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  278. 2, pdf.
  279. Microbiol, 33: 1433
  280. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  281. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  282. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  283. future prospects. Gut pathogens, 1(19): 1-12.
  284. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  285. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  286. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  287. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  288. 526.
  289. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  290. 2, pdf.
  291. 1046-9.
  292. Dairy J 8: 487-490.
  293. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  294. future prospects. Gut pathogens, 1(19): 1-12.
  295. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  296. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  297. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  298. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  299. 526.
  300. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  301. 1046-9.
  302. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  303. 526.
  304. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  305. Microbiol, 33: 1433
  306. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  307. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  308. Microbiol, 33: 1433
  309. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  310. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  311. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  312. Microbiol, 33: 1433
  313. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  314. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  315. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  316. future prospects. Gut pathogens, 1(19): 1-12.
  317. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  318. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  319. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  320. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  321. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  322. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  323. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  324. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  325. future prospects. Gut pathogens, 1(19): 1-12.
  326. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  327. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  328. future prospects. Gut pathogens, 1(19): 1-12.
  329. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  330. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  331. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  332. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  333. Dairy J 8: 487-490.
  334. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  335. future prospects. Gut pathogens, 1(19): 1-12.
  336. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  337. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  338. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  339. 526.
  340. Dairy J 8: 487-490.
  341. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  342. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  343. future prospects. Gut pathogens, 1(19): 1-12.
  344. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  345. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  346. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  347. future prospects. Gut pathogens, 1(19): 1-12.
  348. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  349. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  350. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  351. Dairy J 8: 487-490.
  352. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  353. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  354. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  355. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  356. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  357. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  358. 2, pdf.
  359. 1046-9.
  360. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  361. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  362. future prospects. Gut pathogens, 1(19): 1-12.
  363. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  364. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  365. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  366. future prospects. Gut pathogens, 1(19): 1-12.
  367. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  368. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  369. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  370. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  371. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  372. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  373. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  374. 2, pdf.
  375. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  376. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  377. future prospects. Gut pathogens, 1(19): 1-12.
  378. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  379. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  380. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  381. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  382. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  383. Dairy J 8: 487-490.
  384. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  385. Microbiol, 33: 1433
  386. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  387. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  388. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  389. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  390. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  391. future prospects. Gut pathogens, 1(19): 1-12.
  392. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  393. future prospects. Gut pathogens, 1(19): 1-12.
  394. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  395. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  396. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  397. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  398. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  399. 526.
  400. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  401. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  402. 2, pdf.
  403. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  404. 2, pdf.
  405. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  406. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  407. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  408. 2, pdf.
  409. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  410. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  411. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  412. Dairy J 8: 487-490.
  413. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  414. 1046-9.
  415. future prospects. Gut pathogens, 1(19): 1-12.
  416. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  417. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  418. future prospects. Gut pathogens, 1(19): 1-12.
  419. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  420. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  421. Microbiol, 33: 1433
  422. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  423. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  424. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  425. future prospects. Gut pathogens, 1(19): 1-12.
  426. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  427. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  428. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  429. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  430. future prospects. Gut pathogens, 1(19): 1-12.
  431. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  432. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  433. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  434. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  435. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  436. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  437. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  438. future prospects. Gut pathogens, 1(19): 1-12.
  439. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  440. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  441. Dairy J 8: 487-490.
  442. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  443. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  444. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  445. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  446. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  447. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  448. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  449. future prospects. Gut pathogens, 1(19): 1-12.
  450. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  451. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  452. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  453. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  454. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  455. 2, pdf.
  456. future prospects. Gut pathogens, 1(19): 1-12.
  457. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  458. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  459. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  460. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  461. Dairy J 8: 487-490.
  462. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  463. future prospects. Gut pathogens, 1(19): 1-12.
  464. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  465. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  466. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  467. 1046-9.
  468. future prospects. Gut pathogens, 1(19): 1-12.
  469. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  470. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  471. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  472. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  473. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  474. 1046-9.
  475. 526.
  476. future prospects. Gut pathogens, 1(19): 1-12.
  477. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  478. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  479. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  480. 2, pdf.
  481. 526.
  482. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  483. 526.
  484. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  485. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  486. future prospects. Gut pathogens, 1(19): 1-12.
  487. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  488. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  489. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  490. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  491. 2, pdf.
  492. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  493. future prospects. Gut pathogens, 1(19): 1-12.
  494. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  495. future prospects. Gut pathogens, 1(19): 1-12.
  496. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  497. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  498. future prospects. Gut pathogens, 1(19): 1-12.
  499. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  500. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  501. 526.
  502. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  503. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  504. Microbiol, 33: 1433
  505. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  506. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  507. future prospects. Gut pathogens, 1(19): 1-12.
  508. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  509. Dairy J 8: 487-490.
  510. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  511. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  512. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  513. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  514. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  515. future prospects. Gut pathogens, 1(19): 1-12.
  516. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  517. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  518. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  519. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  520. 526.
  521. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  522. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  523. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  524. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  525. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  526. 1046-9.
  527. Microbiol, 33: 1433
  528. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  529. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  530. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  531. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  532. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  533. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  534. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  535. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  536. 1046-9.
  537. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  538. 526.
  539. 1046-9.
  540. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  541. 526.
  542. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  543. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  544. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  545. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  546. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  547. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  548. 2, pdf.
  549. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  550. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  551. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  552. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  553. Dairy J 8: 487-490.
  554. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  555. Microbiol, 33: 1433
  556. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  557. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  558. Microbiol, 33: 1433
  559. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  560. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  561. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  562. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  563. Dairy J 8: 487-490.
  564. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  565. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  566. Dairy J 8: 487-490.
  567. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  568. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  569. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  570. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  571. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  572. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  573. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  574. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  575. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  576. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  577. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  578. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  579. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  580. Microbiol, 33: 1433
  581. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  582. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  583. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  584. future prospects. Gut pathogens, 1(19): 1-12.
  585. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  586. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  587. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  588. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  589. future prospects. Gut pathogens, 1(19): 1-12.
  590. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  591. Microbiol, 33: 1433
  592. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  593. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  594. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  595. Microbiol, 33: 1433
  596. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  597. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  598. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  599. 2, pdf.
  600. future prospects. Gut pathogens, 1(19): 1-12.
  601. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  602. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  603. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  604. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  605. future prospects. Gut pathogens, 1(19): 1-12.
  606. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  607. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  608. Microbiol, 33: 1433
  609. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  610. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  611. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  612. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  613. Microbiol, 33: 1433
  614. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  615. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  616. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  617. future prospects. Gut pathogens, 1(19): 1-12.
  618. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  619. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  620. future prospects. Gut pathogens, 1(19): 1-12.
  621. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  622. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part

Article Post Production

    No data exists for the row/column.
Creative Commons License
Indian Streams Research Journal by Laxmi Book Publication is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://oldisrj.lbp.world/Default.aspx.
Permissions beyond the scope of this license may be available at http://oldisrj.lbp.world/Default.aspx
Copyright � 2014 Indian Streams Research Journal. All rights reserved
Looking for information? Browse our FAQs, tour our sitemap, or contact ISRJ
Read our Privacy Policy Statement and Plagairism Policy. Use of this site signifies your agreement to the Terms of Use